Mesoblast Limited (MESO): Price and Financial Metrics

Mesoblast Limited (MESO): $14.63

2.13 (-12.71%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

MESO Price/Volume Stats

Current price $14.63 52-week high $19.15
Prev. close $16.76 52-week low $1.61
Day low $13.70 Volume 1,930,100
Day high $15.67 Avg. volume 741,392
50-day MA $10.45 Dividend yield N/A
200-day MA $7.52 Market Cap 1.67B

MESO Stock Price Chart Interactive Chart >


Mesoblast Limited (MESO) Company Bio


Mesoblast Ltd. has established a diverse portfolio of product candidates based on its proprietary allogeneic, off-the-shelf mesenchymal lineage cell-based technology, with multiple active Phase 3 clinical programs. Mesoblast's lead product candidates target major diseases with significant unmet medical needs despite existing therapies. These include chronic heart failure, chronic low back pain due to degenerative disc disease, and immune-mediated conditions such as acute graft versus host disease and biologic refractory rheumatoid arthritis. The company is based in Melbourne, Australia.


MESO Latest News Stream


Event/Time News Detail
Loading, please wait...

MESO Latest Social Stream


Loading social stream, please wait...

View Full MESO Social Stream

MESO Price Returns

1-mo 43.71%
3-mo 113.58%
6-mo 115.78%
1-year 577.31%
3-year 48.68%
5-year 4.05%
YTD 565.00%
2023 -62.20%
2022 -39.38%
2021 -43.46%
2020 15.20%
2019 78.88%

Continue Researching MESO

Here are a few links from around the web to help you further your research on Mesoblast Ltd's stock as an investment opportunity:

Mesoblast Ltd (MESO) Stock Price | Nasdaq
Mesoblast Ltd (MESO) Stock Quote, History and News - Yahoo Finance
Mesoblast Ltd (MESO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!